Literature DB >> 30097504

Fibroblast-Activating Protein: Targeting the Roots of the Tumor Microenvironment.

Jens T Siveke1.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 30097504     DOI： 10.2967/jnumed.118.214361

Source DB:  PubMed          Journal:  J Nucl Med        ISSN： 0161-5505            Impact factor:   10.057


× No keyword cloud information.
  10 in total

1.  68Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancer.

Authors:  Clemens Kratochwil; Paul Flechsig; Thomas Lindner; Labidi Abderrahim; Annette Altmann; Walter Mier; Sebastian Adeberg; Hendrik Rathke; Manuel Röhrich; Hauke Winter; Peter K Plinkert; Frederik Marme; Matthias Lang; Hans-Ulrich Kauczor; Dirk Jäger; Jürgen Debus; Uwe Haberkorn; Frederik L Giesel
Journal:  J Nucl Med       Date:  2019-04-06       Impact factor: 10.057

2.  Time-extended exposure of gastric epithelial cells to secretome of Helicobacter pylori-activated fibroblasts induces reprogramming of gastric epithelium towards pre-cancerogenic and pro-invasive phenotype.

Authors:  Gracjana Krzysiek-Maczka; Aneta Targosz; Tomasz Wrobel; Milena Paw; Urszula Szczyrk; Janusz Opila; Malgorzata Strzalka; Mateusz Wierdak; Piotr Major; Tomasz Brzozowski; Jarosław Czyz; Agata Ptak-Belowska
Journal:  Am J Cancer Res       Date:  2022-03-15       Impact factor: 6.166

3.  Positron emission tomography and computed tomography with [68Ga]Ga-fibroblast activation protein inhibitors improves tumor detection and staging in patients with pancreatic cancer.

Authors:  Yizhen Pang; Long Zhao; Qihang Shang; Tinghua Meng; Liang Zhao; Liuxing Feng; Shuangjia Wang; Ping Guo; Xiurong Wu; Qin Lin; Hua Wu; Weipeng Huang; Long Sun; Haojun Chen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-10-15       Impact factor: 9.236

Review 4.  Tumor microenvironment as a therapeutic target in cancer.

Authors:  Yi Xiao; Dihua Yu
Journal:  Pharmacol Ther       Date:  2020-11-28       Impact factor: 12.310

5.  A methodological investigation of healthy tissue, hepatocellular carcinoma, and other lesions with dynamic 68Ga-FAPI-04 PET/CT imaging.

Authors:  Barbara Katharina Geist; Haiqun Xing; Jingnan Wang; Ximin Shi; Haitao Zhao; Marcus Hacker; Xinting Sang; Li Huo; Xiang Li
Journal:  EJNMMI Phys       Date:  2021-01-22

6.  Fully-automated synthesis of 177Lu labelled FAPI derivatives on the module modular lab-Eazy.

Authors:  Kurtulus Eryilmaz; Benan Kilbas
Journal:  EJNMMI Radiopharm Chem       Date:  2021-04-16

7.  New Fully Automated Preparation of High Apparent Molar Activity 68Ga-FAPI-46 on a Trasis AiO Platform.

Authors:  Chiara Da Pieve; Marta Costa Braga; David R Turton; Frank A Valla; Pinar Cakmak; Karl-Heinz Plate; Gabriela Kramer-Marek
Journal:  Molecules       Date:  2022-01-20       Impact factor: 4.411

Review 8.  Pancreatic Ductal Adenocarcinoma: The Dawn of the Era of Nuclear Medicine?

Authors:  Christopher Montemagno; Shamir Cassim; Nicolas De Leiris; Jérôme Durivault; Marc Faraggi; Gilles Pagès
Journal:  Int J Mol Sci       Date:  2021-06-15       Impact factor: 5.923

Review 9.  FAPI PET/CT in the Diagnosis of Abdominal and Pelvic Tumors.

Authors:  Tianshuo Yang; Long Ma; Haodong Hou; Feng Gao; Weijing Tao
Journal:  Front Oncol       Date:  2022-01-04       Impact factor: 6.244

Review 10.  The Value of 18F-FDG-PET-CT Imaging in Treatment Evaluation of Colorectal Liver Metastases: A Systematic Review.

Authors:  Okker D Bijlstra; Maud M E Boreel; Sietse van Mossel; Mark C Burgmans; Ellen H W Kapiteijn; Daniela E Oprea-Lager; Daphne D D Rietbergen; Floris H P van Velden; Alexander L Vahrmeijer; Rutger-Jan Swijnenburg; J Sven D Mieog; Lioe-Fee de Geus-Oei
Journal:  Diagnostics (Basel)       Date:  2022-03-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.